News

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
One less infant, under the age of six months, was hospitalised each day following the release of the Respiratory Syncytial ...
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.
The Advisory Committee on Immunisation Practices (ACIP) has voted to widen the recommendations on the use of RSV shots to ...
Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our ...
The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the Phase III clinical trial results of ziresovir, a novel RSV-targeted ...